FDA Drug Safety Communication: Prescription Acetaminophen Products to be Limited to 325 mg Per Dosage Unit; Boxed Warning Will Highlight Potential for Severe Liver Failure

U.S. Food and Drug Administration. (2011). FDA Drug Safety Communication: Prescription Acetaminophen Products to be Limited to 325 mg Per Dosage Unit; Boxed Warning Will Highlight Potential for Severe Liver Failure: Prescription Acetaminophen Products to be Limited to 325 mg Per Dosage Unit; Boxed Warning Will Highlight Potential for Severe Liver Failure.

Type

Report

Intellectual base

Grey literature

Year

2011

Link

https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-prescription-acetaminophen-products-be-limited-325-mg-dosage-unit

Cited by

1 citation across 1 artifact.

Domain-specific

• Therapeutic Duplication
  • Precisely because the harm lives in the hidden overlap, the FDA in 2011 asked manufacturers to cap acetaminophen at 325 mg per tablet in prescription combination products and mandated a boxed warning, an intervention aimed at the set-level exposure rather than any single order

    Supported in partVerified against the source

    Read by an automated reader; not a human review. How support was checked

Verification

Does it exist? Not checked yet. This entry carries no identifier to resolve. It was extracted from the citation as written in the article, normalized, and deduplicated against the rest of the registry.

Does it back the claim? Read against the text for 1 of 1 citation: 1 supported in part. Each verdict is shown under its citation below, with what in the work backs the sentence.

Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.

See how references were verified.

Registry ID ref:ef0a3ca597b1 · see in the full table